OncoCyte Corp (OCX)
2.90
-0.10
(-3.33%)
USD |
NASDAQ |
Nov 04, 16:00
2.82
-0.08
(-2.76%)
Pre-Market: 20:00
OncoCyte Price: 2.90 for Nov. 4, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 04, 2024 | 2.96 | 2.96 | 2.885 | 2.90 | 21516.00 |
| Nov 01, 2024 | 3.01 | 3.04 | 2.900 | 3.00 | 27219.00 |
| Oct 31, 2024 | 3.006 | 3.068 | 2.988 | 3.03 | 10964.00 |
| Oct 30, 2024 | 3.000 | 3.08 | 2.997 | 3.02 | 3973.00 |
| Oct 29, 2024 | 3.08 | 3.11 | 3.02 | 3.10 | 19996.00 |
| Oct 28, 2024 | 3.095 | 3.16 | 3.00 | 3.10 | 35663.00 |
| Oct 25, 2024 | 3.021 | 3.13 | 3.021 | 3.04 | 2477.00 |
| Oct 24, 2024 | 3.20 | 3.20 | 3.04 | 3.05 | 62853.00 |
| Oct 23, 2024 | 3.07 | 3.15 | 3.04 | 3.15 | 19164.00 |
| Oct 22, 2024 | 3.13 | 3.13 | 3.04 | 3.08 | 11307.00 |
| Oct 21, 2024 | 3.20 | 3.20 | 3.04 | 3.12 | 11316.00 |
| Oct 18, 2024 | 2.99 | 3.150 | 2.99 | 3.13 | 10337.00 |
| Oct 17, 2024 | 3.03 | 3.256 | 2.991 | 3.12 | 10831.00 |
| Oct 16, 2024 | 3.26 | 3.26 | 3.028 | 3.11 | 91315.00 |
| Oct 15, 2024 | 3.14 | 3.20 | 3.027 | 3.12 | 30447.00 |
| Oct 14, 2024 | 3.01 | 3.194 | 3.00 | 3.12 | 23660.00 |
| Oct 11, 2024 | 3.15 | 3.15 | 2.98 | 3.05 | 32329.00 |
| Oct 10, 2024 | 3.017 | 3.10 | 2.95 | 3.10 | 30007.00 |
| Oct 09, 2024 | 3.11 | 3.11 | 2.960 | 3.07 | 38094.00 |
| Oct 08, 2024 | 3.06 | 3.15 | 2.965 | 3.04 | 33940.00 |
| Oct 07, 2024 | 3.04 | 3.10 | 2.975 | 3.01 | 85205.00 |
| Oct 04, 2024 | 2.900 | 2.955 | 2.85 | 2.89 | 25035.00 |
| Oct 03, 2024 | 3.18 | 3.200 | 2.94 | 2.98 | 40797.00 |
| Oct 02, 2024 | 2.90 | 3.05 | 2.84 | 3.05 | 23041.00 |
| Oct 01, 2024 | 2.88 | 2.99 | 2.831 | 2.99 | 6448.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.08
Minimum
Nov 08 2023
130.00
Maximum
Feb 16 2021
32.17
Average
23.20
Median
Apr 29 2022
Price Benchmarks
| Fonar Corp | 14.55 |
| XWELL Inc | 1.745 |
| ProPhase Labs Inc | 2.19 |
| Applied DNA Sciences Inc | 0.183 |
| Veracyte Inc | 35.02 |
Price Related Metrics
| PS Ratio | 26.69 |
| Price to Book Value | 2.150 |
| Earnings Yield | -150.7% |
| Market Cap | 48.82M |